Announcements Trials
Browse Landscape

Phase

Phase NA 43Phase 2 37Phase 1 26Phase 3 13Phase 4 7Phase 1/2 7Phase EARLY_PHASE1 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 182Neoplasms 115Prostatic Neoplasms 103Multiple Myeloma 85Glioblastoma 82Pancreatic Neoplasms 76Glioma 65Brain Neoplasms 60Lung Neoplasms 58Head and Neck Neoplasms 57Colorectal Neoplasms 55Melanoma 54Carcinoma, Non-Small-Cell Lung 53Leukemia, Myeloid, Acute 51Carcinoma, Hepatocellular 51Recurrence 47Squamous Cell Carcinoma of Head and Neck 46Ovarian Neoplasms 45Lymphoma 39Lymphoma, Non-Hodgkin 37Lymphoma, B-Cell 36Sarcoma 35Stomach Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 34Neoplasm Metastasis 34Solid Tumor 31Hematologic Neoplasms 31Carcinoma, Renal Cell 30Polycystic Ovary Syndrome 27Burkitt Lymphoma 27

Interventions

Nivolumab 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Acquired Immunodeficiency Syndrome × Clear all
NCT03316274 2024-06-25

Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma

University of California, San Francisco

Phase EARLY_PHASE1 Completed
12 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT02823847 2022-02-14

Non Invasive Oral Cancer Screening Among HIV Infected Individuals

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed
44 enrolled

Acquired Immunodeficiency Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡